Direct-to-Consumer Laboratory Testing Market (By Product: Medical Genetic Laboratory Testing, Routine Clinical Laboratory Testing; By Test Type: Genetic Testing, COVID-19, Cancer, Diabetes Testing, Disease Risk Assessment Testing, Sexually Transmitted Disease Testing, Routine Testing, Complete Blood Count, CNS-related/Neurological Disease, Thyroid Stimulating Hormone Testing, Other; By Sample Type) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Direct-to-Consumer Laboratory Testing Market
5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Direct-to-Consumer Laboratory Testing Market, By Product
8.1. Direct-to-Consumer Laboratory Testing Market, by Product, 2023-2032
8.1.1 Medical Genetic Laboratory Testing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Routine Clinical Laboratory Testing
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Direct-to-Consumer Laboratory Testing Market, By Test Type
9.1. Direct-to-Consumer Laboratory Testing Market, by Test Type, 2023-2032
9.1.1. Genetic Testing
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. COVID-19
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Cancer
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Diabetes Testing
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Disease Risk Assessment Testing
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Sexually Transmitted Disease Testing
9.1.6.1. Market Revenue and Forecast (2020-2032)
9.1.7. Routine Testing
9.1.7.1. Market Revenue and Forecast (2020-2032)
9.1.8. Complete Blood Count
9.1.8.1. Market Revenue and Forecast (2020-2032)
9.1.9. Complete Blood Count
9.1.9.1. Market Revenue and Forecast (2020-2032)
9.1.10. Thyroid Stimulating Hormone Testing
9.1.10.1. Market Revenue and Forecast (2020-2032)
9.1.11. Other
9.1.11.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Direct-to-Consumer Laboratory Testing Market, By Sample Type
10.1. Direct-to-Consumer Laboratory Testing Market, by Sample Type, 2023-2032
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Urine
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Saliva
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Direct-to-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)
Chapter 12. Company Profiles
12.1. 23andMe, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ambry Genetics Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ancestry.com LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Any Lab Test Now, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Color Genomics, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Counsyl, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. DanteLabs Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Direct Laboratory Services, LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Eastern Biotech & Life Sciences
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. EasyDNA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample